Eryilmaz Lab

Massachusetts General Hospital

Boston · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2025

Mechanisms of Cognitive Control Impairment in ME/CFS and PASC-ME/CFS

ABSTRACT Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a symptom-based diagnosis characterized by severe debilitating fatigue, cognitive dysfunction, and widespread pain. Most cases of ME/CFS begin with a viral infection or involve multiple exposures to pathogens over time. Soon after the onset of the COVID-19 pandemic, a significant portion of patients infected with SARS-CoV-2 developed chronic symptoms that overlap greatly with those of ME/CFS. Among the post-acute sequelae of COVID-19 (PASC), “brain fog” symptoms have been widely reported including in patients with mild initiating infection. Many PASC patients meet the diagnostic criteria for ME/CFS after 6 months of…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Massachusetts General Hospital